Magnus SteigedalDirector Strategic Area and Researcher DMF faculty administration Department of Cancer Research and Molecular Medicine Faculty of Medicine Centre of Molecular Inflammation Research (SFF-CEMIR)
firstname.lastname@example.org +47 72825359 +47 97706661
Background and activities
I am the Director of NTNU's Thematic Strategic Area of Health, Welfare and Technology. As a researcher, I want to understand bacterial infections from the microbe's point of view, and I want to identify new potential targets for antibiotics, for tuberculosis in particular.
Main responsibilities and tasks
- Director of NTNU's Strategic Thematic Area of Health, Welfare and Technology
- Researcher in microbiology
- Project Manager for the RCN GLOBVAC programme Young Scientist Grant
- Supervisor for PhD Candidates
- 2014– Director of NTNU's Strategic Thematic Area of Health, Welfare and Technology
- 2013–2016 Project Manager for the RCN GLOBVAC programme Young Scientist Grant
- 2012– Researcher, Center of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Faculty of Medicine, both NTNU
- 2012–2015 Project Manager for the NTNU / Helse Midt-Norge RHF grant
- 2010–2011 Research Fellow, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, USA
- 2007–2012 Project Co-Manager for the NTNU / Helse Midt-Norge RHF grant
- 2006–2012 Post doc., Department of Cancer Research and Molecular Medicine, Faculty of Medicine, NTNU
- 2001–2006 PhD in Biotechnology, Department of Biotechnology, NTNU
- 2012–2014 Member of the Board of Directors, NTNU
- 2012–2014 Leader of the Norwegian Biochemical Society (NBS) Trondheim
- 2012–2013 Deputy Board Member, Norwegian Forum for Global Health Research
- 2009– Member of the Election Board, Faculty of Medicine, NTNU
- Evaluation committees for PhD theses
Scientific, academic and artistic work
A selection of recent journal publications, artistic productions, books, including book and report excerpts. See all publications in the database
- (2015) A novel antimycobacterial compound acts as an intracellular iron chelator. Antimicrobial Agents and Chemotherapy. vol. 59 (4).
- (2014) Mycobacterial Esx-3 Requires Multiple Components for Iron Acquisition. mBio. vol. 5 (3:e01073-14).
- (2014) Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection. Journal of Immunology. vol. 193 (12).
- (2013) Dynamics of immune effector mechanisms during infection with Mycobacterium aviumin C57BL/6 mice. Immunology. vol. 140 (2).
- (2010) Intracellular Mycobacterium avium Intersect Transferrin in the Rab11(+) Recycling Endocytic Pathway and Avoid Lipocalin 2 Trafficking to the Lysosomal Pathway. Journal of Infectious Diseases. vol. 201 (5).
- (2008) The Azotobacter vinelandii AlgE mannuronan C-5-epimerase family is essential for the in vivo control of alginate monomer composition and for functional cyst formation. Environmental Microbiology. vol. 10 (7).
- (2008) The Acinetobacter sp chnB promoter together with its cognate positive regulator ChnR is an attractive new candidate for metabolic engineering applications in bacteria. Metabolic engineering. vol. 10 (2).
- (2006) Identification and characterization of an Azotobacter vinelandii type I secretion system responsible for export of the AlgE-Type mannuronan C-5-epimerases. Journal of Bacteriology. vol. 188 (15).
- (2006) The Azotobacter vinelandii mannuronan C5-epimerases: their biological functions and new tools useful for their future in vivo biotechnological application. 2006. ISBN 82-471-7775-7.
- (2001) Epimerisering av alginat kan være knyttet til ekstrakromosomalt DNA i Azotobacter chroococcum. 2001.